Navigation Links
How well does clot-busting drug work in stroke patients?
Date:11/9/2010

MAYWOOD, Ill. -- The clot-busting drug rt-PA remains the most beneficial proven emergency treatment for strokes caused by blood clots, according to an editorial in the November issue of Archives of Neurology by Dr. Jos Biller.

"The benefits of treatment outweigh the risks in patients treated with intravenous rt-PA within 4.5 hours of symptom onset," Biller wrote. Biller is chairman of the Department of Neurology at Loyola University Chicago Stritch School of Medicine and an internationally recognized expert on stroke care.

Most strokes are ischemic, meaning they are caused by blood clots that block blood flow in the brain. Brain cells begin dying when they are starved of blood supply. But if administered soon enough, an IV drug known as recombinant tissue plasminogen activator (rt-PA) can dissolve clots, restore blood flow and limit damage.

Biller's editorial is about a study, published in the same issue, by Dr. Ioan-Paul Muresan and colleagues at Assistance Publique -- Hopitaux de Paris. The study found that stroke patients who show improvement within one hour of receiving rt-PA were more likely to do well three months later,

Researchers followed 120 patients who received rt-PA and found that 22 (18.3 percent) showed significant improvement within one hour of treatment. After three months, 15 of these patients (68.2 percent) had a favorable outcome. By comparison, only 29.6 percent of patients who did not show early improvement had a favorable outcome at three months.

These findings suggest that a quick bedside assessment "can predict good response," Biller wrote. Conversely, a poor response in the first hour can predict a poor outcome at three months. In such cases, physicians "can begin consideration of mechanical interventions, intra-arterial therapy or other alternative therapies."

Additional studies involving larger populations at multiple centers "are needed to address the significance and clinical utility of the intriguing findings of this carefully conducted study," Biller wrote.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Longer Time Frame for Clot-Busting Drug May Help Beat Stroke
2. Early Treatment With Clot-Busting Drug Best After Stroke
3. Higher Statin Doses Linked to Fewer Heart Attacks, Stroke
4. Using CT, radiologists can pinpoint cause of some strokes
5. New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients
6. Vitamin E May Pose Slight Bleeding-Stroke Risk
7. MRI Images May Pinpoint Time of Stroke
8. MRI may help determine time of stroke onset
9. Weekend Admissions Worse for Stroke Victims: Study
10. Childhood stroke study identifies the contraceptive pill and smoking as risk factors
11. Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CO (PRWEB) , ... March 28, 2017 , ... ... reasonable assumption that in order to improve teacher quality, the field must first ... swinging from one popular reform to the next” and that decades of input- ...
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... in state legislatures and Congress to protect parental rights and civil liberties, and ... safety in America. , The demonstration coincides with a press conference taking place ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... all holidays (IBT World Travel Trends Report). As travelers visit both urban destinations, ... in temperatures, and prolonged sun exposure. In response, the outdoor industry has blurred ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... for and by physicians, announced today the launch of a free, public-facing tool ... Via Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... NetworkNewsWire Editorial Coverage  ... There are a number of advantages ... economic arguments also favor its legalization. The benefits include increased ... to legalize and regulate marijuana requires an ecosystem of support ... SING Profile ), American Cannabis Company (OTC: AMMJ), Kush Bottles, ...
(Date:3/29/2017)... AVIV, Israel , March 29, 2017 ... agreement in which Exeltis will obtain exclusive marketing rights for Neurim,s ... ... an age-appropriate drug targeted to treat sleep disorders in children with ... be the first sleep medication approved for children. The ...
Breaking Medicine Technology: